Jaidas Cadillac was conducting antidote tests on children.
The Center has informed the Delhi court that antidotes for 12 to 18 year olds are coming to India. Zydus Cadila was experimenting with antidotes on children. Ahmedabad-based pharmaceutical company has completed a clinical trial, that’s the news.
Earlier, Zydus Cadila had sought approval from the Drug Controller General of India to use the vaccine in India on an emergency basis. The company said it would make 12 crore vaccines a year with the permission of the center.
Zydus Cadilla has claimed that since the trial also showed good results in the second wave of corona, the vaccine is being called effective by the company. The vaccine could work against the Delta variant, the agency claimed.
Zycov-D is a plasmid DNA vaccine, claims the Zydus Cadillac organization. DNA molecule known as plasmid. These plasmids can produce spike protein SARS-CoV-2 to prevent Covid 19 infection. It helps the body make antibodies very quickly, which helps build immunity.